Janssen Search
Search results
Johnson & Johnson strengthens pipeline to lead in atopic dermatitis with the completion of the acquisition of Yellow Jersey Therapeutics, gaining ownership of NM26
Jul 11, 2024 NM26 is a Phase 2-ready, first-in-class bispecific antibody targeting two clinically proven pathways in atopic dermatitis (AD) The Company is leveraging a multi-pathway approach to transform treatment in atopic dermatitis and other immune ...
Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations
Apr 21, 2023 Belgium Approval for AKEEGA ® is based on results from the Phase 3 MAGNITUDE study, a prospectively designed precision medicine study that includes the largest cohort to date of BRCA1/2-positive patients with untreated metastatic castration ...
Transparency of Clinical Trial Data
Article Type: Clinical Trials Clinical Trial Data Transparency At Janssen, we believe transparency of clinical trial data advances science and medicine and is in the best interest of the patients who use our pharmaceutical products and providers who ...
TREMFYA® (guselkumab) demonstrates superiority versus STELARA® (ustekinumab) in Phase 3 Crohn's disease program
May 23, 2024 Data from GALAXI 2 & 3 showed TREMFYA® was superior to STELARA® in all pooled endoscopic endpoints Washington, D.C. (May 21, 2024) – Johnson & Johnson today announced the first Phase 3 results for TREMFYA® (guselkumab) in adult ...
International Women in Science Day
In order to achieve full and equal access to and participation in science for women and girls, and further achieve gender equality and the empowerment of women and girls, February 11 has been designated International Women in Science Day Event Date: ...
International Day of Women And Girls in Science
To achieve full and equal access to and participation in science for women and girls, and further achieve gender equality and the empowerment of women and girls, February 11 has been designated International Day of Women and Girls in Science Day. Event ...
J.P. Morgan Healthcare Conference
The 39th annual J.P. Morgan Healthcare Conference will take place virtually on January 11–14, 2021. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together ...
American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Annual Meeting
The 2021 Genitourinary (GU) Cancers Symposium will take place virtually February 11-13. It is a three-day scientific and educational meeting designed to meet the needs of physicians and other members of the cancer care and research community who diagnose, ...
Annual Biotech Showcase
The 13th Annual Biotech Showcase will take place virtually January 11–15, 2021. Biotech Showcase™ is an investor conference, during the 2021 J. P. Morgan Healthcare Conference, devoted to providing private and public biotechnology and life sciences ...
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
May 18, 2023 United States Launch of Multidisciplinary Council of Experts Call-to-Action During EHA Demonstrates Continued Commitment to Innovation in Multiple Myeloma RARITAN, N.J., May 18, 2023 — The Janssen Pharmaceutical Companies of Johnson & ...